Arca
Skip to content
Tools
Tools

SCTR: Secretin receptor

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

G protein-coupled receptor activated by secretin (SCT), which is involved in different processes such as regulation of the pH of the duodenal content, food intake and water homeostasis.

  • Drugs that act on it: 3
  • Approved: 3
  • In phases 1 to 3: 0
  • Sponsors: 2

Who Is On It, and How Far Along

Every drug ChEMBL records acting on SCTR, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide

Approved3

  • Secretin
  • Secretin synthetic human
  • Secretin synthetic porcine

Phase 30

    Phase 20

      Phase 10

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Secretin receptor agonist.
        SecretinApprovedFerring PharmaceuticalsProtein or peptideAgonist—12—
        Secretin synthetic humanApprovedChirhoclinProtein or peptideAgonist—12—
        Secretin synthetic porcineApprovedChirhoclinProtein or peptideAgonist—0—

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Secretin in Ex-situ Liver PerfusionSecretin, Secretin synthetic humanPhase 1 / Phase 2Enrolling by invitationErasmus Medical Center2026-06-16
        A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy SubjectsSecretin, Secretin synthetic humanPhase 4Active, not recruitingMayo Clinic2025-12-16
        The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal AdenocarcinomaSecretin, Secretin synthetic human—Not yet recruitingCharles University, Czech Republic2025-02-04
        The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)Secretin, Secretin synthetic human—Enrolling by invitationAdenocyte, LLC2024-02-26
        The LINFU® U.S. Registry for the in the General Population Without Risk FactorsSecretin, Secretin synthetic human—Not yet recruitingAdenocyte, LLC2024-02-26
        The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of DiseaseSecretin, Secretin synthetic human—Not yet recruitingAdenocyte, LLC2024-02-26
        Imaging Biomarkers of Pancreatic Function and DiseaseSecretin, Secretin synthetic humanPhase 4Enrolling by invitationChildren's Hospital Medical Center, Cincinnati2022-12-21
        Secretin in RefeedingSecretin, Secretin synthetic human—RecruitingUniversity of California, Los Angeles2022-02-11

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Type 2 diabetes mellitus
        0.52
        Gastrin-producing neuroendocrine tumor
        0.38
        Neurodegenerative disease
        0.37
        Autism
        0.35
        Rheumatic disorder
        0.20
        Cardiac transplant
        0.20
        Neuroendocrine neoplasm
        0.19
        Familial idiopathic steroid-resistant nephrotic syndrome
        0.07

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1925, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P47872, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.